Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

Also called NCT05318092

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 122 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05318092
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05318092. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-19 (actual); primary completion 2024-01-04 (actual). Results posted on 2024-07-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
Acronym
APEX-AV
Condition
Acute Pulmonary Embolism
Intervention (Device)
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE
Lead sponsor
Angiodynamics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05318092
Content hash
ceca2e2d5aa42ec87f9c9a30154e308c6d818b01231d172940352c125f040ea2